Moving the Pendulum for Glioblastoma Treatment: One Injection at a Time

Authors

Xizi Wu
Christopher Alvarez-Breckenridge

Publication Date

8-3-2023

Journal

The Oncologist

Abstract

Despite advances, glioblastoma is characterized by exceptionally high rates of recurrence and resistance to therapy. This commentary remarks on the recently published article by Maruyama et al, which reports the PMDA review of G47Δ injection for malignant glioma, in which the efficacy and safety results of G47Δ were evaluated and approval conditions clarified.

Keywords

Humans, Glioblastoma

Comments

PMID: 37130338